In this CME presentation, Dr. Kevin Gibson provides an overview of the classification of Interstitial Lung Disease or ILDs.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Review the clinical radiographic and pathologic criteria for the diagnosis of idiopathic pulmonary fibrosis
  • Review epidemiology and natural history of idiopathic pulmonary fibrosis
  • Review past and current clinical trials of novel therapeutics for idiopathic pulmonary fibrosis

Reading Resources:

  1. Comprehensive Care of the Patient with Idiopathic Pulmonary Fibrosis. Lee JS, McLaughlin S, Collard HR. Curr Opin Pulm Med. 2011 Sept;17(5):348-54. PMID 21760508.
  2. Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium. Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, duBois RM. Chest. 2011 Jul;140(1):221-9. PMID 21729893.
  3. Emerging Drugs for Idiopathic Pulmonary Fibrosis. Selman M, Pardo A, Richeldi L, Cerri S. Expert Opin Emerg Drugs. 2011 June;16(2):341-62. Epub 2011 Mar 17. PMID 2140128.

Disclosures:

Dr. Gibson has no relevant relationships with any entities producing healthcare goods or services.


Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to .5 contact hours.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 5/17/2012 | Last Modified On: 5/17/2012 | Expires: 5/16/2013

Dr. Gibson provides an overview of the classification of ILDs, major clinical, radiologic, and pathologic features, pitfalls

in diagnosis, and management of ILDs. Past and current clinical trials are also discussed.

Educational objectives:

Upon completion of this activity, participants should be able to:

Review the clinical radiographic and pathologic criteria for the diagnosis of idiopathic pulmonary fibrosis
Review epidemiology and natural history of idiopathic pulmonary fibrosis
Review past and current clinical trials of novel therapeutics for idiopathic pulmonary fibrosis

Reading Resources:

Comprehensive Care of the Patient with Idiopathic Pulmonary Fibrosis. Lee JS, McLaughlin S, Collard HR. Curr Opin Pulm Med.

2011 Sept;17(5):348-54. PMID 21760508.
Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium. Nathan SD, Shlobin OA, Weir N, Ahmad

S, Kaldjob JM, Battle E, Sheridan MJ, duBois RM. Chest. 2011 Jul;140(1):221-9. PMID 21729893.
Emerging Drugs for Idiopathic Pulmonary Fibrosis. Selman M, Pardo A, Richeldi L, Cerri S. Expert Opin Emerg Drugs. 2011

June;16(2):341-62. Epub 2011 Mar 17. PMID 2140128.

Disclosures:

Dr. Gibson has no relationships with any entities producing healthcare goods or services.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education

(ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1

CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to .5 contact

hours.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link

to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to

access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 5/10/2011 | Last Modified On: 5/10/2011 | Expires: 5/9/2012
This course has been expired.